Inflammation-mediated facial nodules to compounded tirzepatide

Luke C Moore, Kara Hurley, Angela Yen Moore · 2026

Read Inflammation-mediated facial nodules to compounded tirzepatide by Luke C Moore, Kara Hurley, Angela Yen Moore (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13471048.txt.

Description

Luke C Moore, Kara Hurley, and Angela Yen Moore write in 2026, in reply to a critic, defending their view that facial nodules after compounded tirzepatide injections were inflammatory rather than infectious. Tirzepatide is a popular diabetes and weight loss drug, and a compounded version was linked to nodules at earlier filler sites in their patient. A responding letter had proposed infection instead.

The authors note that two rounds of the antibiotic doxycycline brought no improvement, arguing against bacteria. Improvement on isotretinoin, a drug that calms inflammation, pointed the other way. Nodules also stopped after the compounded drug was halted, even though filler injections continued, and they returned weeks after a fresh compounded dose. No biopsy was taken, given the facial location and the patient refusal, a limit the authors concede.

Catalog record

CREATORLuke C Moore, Kara Hurley, Angela Yen Moore
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE2136
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13471048

Browse the full library · About the Tower of Babel